Joan Rosenbaum Asarnow1, Lars Mehlum2. 1. Department of Psychiatry and Behavioral Sciences, University of California, Los Angeles, Los Angeles, CA, USA. 2. National Centre for Suicide Research and Prevention, University of Oslo, Oslo, Norway.
Abstract
BACKGROUND: Suicide is a leading cause of death globally in youths, and suicidal behavior and self-harm are major clinical concerns. This article updates the previous practitioner review (2012) with the aims of integrating new research evidence, including that reported in this Special Issue. METHODS: The article reviews scientific evidence related to steps in the care pathway for identifying and treating youths with elevated suicide/self-harm risk, specifically: (a) screening and risk assessment; (b) treatment; and (c) community-level suicide prevention strategies. RESULTS: Review of current evidence indicates that major advances have been achieved in knowledge regarding clinical and preventive practices for reducing suicide and self-harm risk in adolescents. The evidence supports the value of brief screeners for identifying youths with elevated suicide/self-harm risk and the efficacy of some treatments for suicidal and self-harm behavior. Dialectical behavior therapy currently meets Level 1 criteria (2 independent trials supporting efficacy) as the first well-established treatment for self-harm, and other approaches have shown efficacy in single randomized controlled trials. The effectiveness of some community-based suicide prevention strategies for reducing suicide mortality and suicide attempt rates has been demonstrated. CONCLUSIONS: Current evidence can guide practitioners in delivering effective care for youth suicide/self-harm risk. Treatments and preventive interventions that address the psychosocial environment and enhance the ability of trusted adults to protect and support youths, while also addressing the psychological needs of youths appear to yield the greatest benefits. Although additional research is needed, our current challenge is to do our best to effectively utilize new knowledge to improve care and outcomes in our communities.
BACKGROUND: Suicide is a leading cause of death globally in youths, and suicidal behavior and self-harm are major clinical concerns. This article updates the previous practitioner review (2012) with the aims of integrating new research evidence, including that reported in this Special Issue. METHODS: The article reviews scientific evidence related to steps in the care pathway for identifying and treating youths with elevated suicide/self-harm risk, specifically: (a) screening and risk assessment; (b) treatment; and (c) community-level suicide prevention strategies. RESULTS: Review of current evidence indicates that major advances have been achieved in knowledge regarding clinical and preventive practices for reducing suicide and self-harm risk in adolescents. The evidence supports the value of brief screeners for identifying youths with elevated suicide/self-harm risk and the efficacy of some treatments for suicidal and self-harm behavior. Dialectical behavior therapy currently meets Level 1 criteria (2 independent trials supporting efficacy) as the first well-established treatment for self-harm, and other approaches have shown efficacy in single randomized controlled trials. The effectiveness of some community-based suicide prevention strategies for reducing suicide mortality and suicide attempt rates has been demonstrated. CONCLUSIONS: Current evidence can guide practitioners in delivering effective care for youth suicide/self-harm risk. Treatments and preventive interventions that address the psychosocial environment and enhance the ability of trusted adults to protect and support youths, while also addressing the psychological needs of youths appear to yield the greatest benefits. Although additional research is needed, our current challenge is to do our best to effectively utilize new knowledge to improve care and outcomes in our communities.
Authors: Thomas Niederkrotenthaler; Steven Stack; Benedikt Till; Mark Sinyor; Jane Pirkis; David Garcia; Ian R H Rockett; Ulrich S Tran Journal: JAMA Psychiatry Date: 2019-09-01 Impact factor: 21.596
Authors: Jamie Zelazny; Nadine Melhem; Giovanna Porta; Candice Biernesser; John G Keilp; J John Mann; Maria A Oquendo; Barbara Stanley; David A Brent Journal: J Child Psychol Psychiatry Date: 2019-07-24 Impact factor: 8.982
Authors: Kelly Posner; Gregory K Brown; Barbara Stanley; David A Brent; Kseniya V Yershova; Maria A Oquendo; Glenn W Currier; Glenn A Melvin; Laurence Greenhill; Sa Shen; J John Mann Journal: Am J Psychiatry Date: 2011-12 Impact factor: 18.112
Authors: Dennis Ougrin; Richard Corrigall; Jason Poole; Toby Zundel; Mandy Sarhane; Victoria Slater; Daniel Stahl; Paula Reavey; Sarah Byford; Margaret Heslin; John Ivens; Maarten Crommelin; Zahra Abdulla; Daniel Hayes; Kerry Middleton; Benita Nnadi; Eric Taylor Journal: Lancet Psychiatry Date: 2018-05-03 Impact factor: 27.083
Authors: Udita Iyengar; Natasha Snowden; Joan R Asarnow; Paul Moran; Troy Tranah; Dennis Ougrin Journal: Front Psychiatry Date: 2018-11-23 Impact factor: 4.157
Authors: Joan Rosenbaum Asarnow; Sunhye Bai; Kalina N Babeva; Molly Adrian; Michele S Berk; Lauren D Asarnow; Damla Senturk; Marsha M Linehan; Elizabeth McCauley Journal: Suicide Life Threat Behav Date: 2020-07-24
Authors: Eduardo Fonseca-Pedrero; Susana Al-Halabí; Alicia Pérez-Albéniz; Martin Debbané Journal: Int J Environ Res Public Health Date: 2022-02-04 Impact factor: 3.390
Authors: Jason D Jones; Rhonda C Boyd; Monica E Calkins; Tyler M Moore; Annisa Ahmed; Ran Barzilay; Tami D Benton; Raquel E Gur; Ruben C Gur Journal: J Child Psychol Psychiatry Date: 2020-03-30 Impact factor: 8.982
Authors: Katrina G Witt; Sarah E Hetrick; Gowri Rajaram; Philip Hazell; Tatiana L Taylor Salisbury; Ellen Townsend; Keith Hawton Journal: Cochrane Database Syst Rev Date: 2021-03-07